💸 The Tape

Germany's newly forming coalition government has pumped the brakes on rolling back cannabis legalization, offering reform advocates and the country’s budding industry a sigh of relief—and some much-needed clarity.

Following a pivotal national election earlier this year, centrist coalition partners have agreed to keep the Cannabis Consumption Act (CanG) in place for now, opting instead for an “open-ended evaluation” of the law in fall 2025, according to a 146-page agreement unveiled Wednesday by the Christian Democratic Union (CDU), Christian Social Union (CSU), and the Social Democratic Party (SPD).

In political speak, that’s basically: "We're not killing the law (yet), but we'll be watching."

That’s a far cry from the pre-election saber-rattling from the CDU and CSU, who previously vowed to repeal the cannabis law outright, warning it would "protect dealers" and “expose our children” to marijuana. But without full consensus in the coalition, that plan went up in smoke.

“For all those who thought this was important: #CanG stays!” posted Carmen Wegge, an SPD member of the Bundestag, punctuating the announcement with some celebratory social media relief.

The German Hemp Association joined the applause, declaring that CanG “won’t be reversed for now,” signaling just how precarious the situation seemed following February’s election.

Industry leaders also chimed in. Niklas Kouparanis, CEO of Bloomwell Group, said Germany’s cannabis sector was “breathing a sigh of relief,” predicting more jobs, investment, and an eventual million-patient medical market. “Legal cannabis is here to stay,” he added.

And the public seems to agree. Polling shows 59% of eligible German voters support legal, licensed cannabis sales—up from below 50% just a few years ago. Unsurprisingly, CDU/CSU voters were the only group where rollback support was in the majority.

Under the Cannabis Consumption Act, personal possession and home cultivation became legal last April. Cannabis social clubs are already operating, and several cities—like Frankfurt and Hanford—are moving forward with pilot sales programs. Meanwhile, the federal government greenlit research-focused commercial pilots late last year.

Internationally, Germany has played host to a growing cannabis diplomacy effort, inviting officials from countries like Luxembourg, Malta, the Netherlands, and Switzerland to discuss the ins and outs of legalization. Germany’s drug commissioner even toured California dispensaries to take notes.

So while the coalition’s compromise may lack fireworks, it sends a clear signal: Germany's cannabis experiment is still very much alive—and now has some breathing room to prove itself before the next political showdown in 2025.

As for the CDU and CSU? For now, they’ll have to settle for a seat at the evaluation table—rather than an undo button.

📈 Dog Walkers.

Trulieve Expands In Tampa

What’s Going On Here:Trulieve (CSE: TRUL | OTCQX: TCNNF) is opening a new medical cannabis dispensary in St. Petersburg, FL at 3210 Central Avenue, with a grand opening event on Friday, April 11 at 9 a.m. featuring music, specials, and patient education sign-ups.

The location offers drive-through, walk-in, and express pickup, carrying Trulieve’s in-house brands like Muse and Sweet Talk, plus exclusives like Khalifa Kush and Alien Labs. Veterans get 20% off, and first-time customers receive 60% off their first order.

Why This Matters: FL will continue to be a growth driver for Trulieve.

Glass House Inks Deal With Cal

Whats Going On Here: Glass House Brands (CBOE CA: GLAS.A.U | OTCQX: GLASF) has teamed up with UC Berkeley on a groundbreaking hemp research collaboration. The partnership will explore medicinal product development, genetics, supply chain sustainability, and AI automation, while also addressing hemp policy and regulatory clarity for California growers.

Glass House, which began hemp R&D in 2024 and can produce up to 240,000 lbs of biomass annually, sees this as a strategic move to scale nationally—pending Farm Bill and regulatory developments. CEO Kyle Kazan called it a first-of-its-kind alliance that positions Glass House to lead in a potentially massive hemp-derived market.

Why This Matters: Interesting development, we can thank S1 for not enabling this study to be leveraging traditional cannabis.

🗞️ The News

📺 YouTube

Germany's Coalition Confirms No Changes to Cannabis Reform | Trade to Black

What we will cover:

✅ Host Shadd Dales and co-host Anthony Varrell discuss the recent announcement out of Germany, where the coalition government confirmed it will not reverse the CanG adult-use cannabis law. This decision reinforces Germany’s role as a global leader in cannabis reform—a key signal for cannabis investors and companies focused on international cannabis markets.

Joining the show is Dr. Julian Wichmann, CEO and co-founder of Bloomwell Group, the largest medical cannabis marketplace in Germany. Often compared to the “Amazon of cannabis,” Bloomwell has seen prescriptions surge over 1,000% since legalization, highlighting the momentum behind European cannabis stocks.

Shadd and Julian unpack the regulatory climate, the threat of reclassification, and how public support is keeping reform on track. They also explore how Bloomwell is streamlining supply chains and scaling digital infrastructure across Germany’s cannabis ecosystem.